Mark Mortenson - 17 Feb 2023 Form 4 Insider Report for Clene Inc. (CLNN)

Role
Chief Science Officer
Signature
/s/ Jerry Miraglia POA
Issuer symbol
CLNN
Transactions as of
17 Feb 2023
Transactions value $
$0
Form type
4
Filing time
21 Feb 2023, 15:15:35 UTC
Previous filing
07 Nov 2022
Next filing
03 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLNN Stock Options (Right to buy) Award $0 +75,000 $0 75,000 17 Feb 2023 Common Stock 75,000 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on February 17, 2023 as an option for 75,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.28 per share. The options vest in full on August 17, 2023.